FORA Forian Inc.
USHealthcareAs of 2026-05-15 16:00
Why FORA matters now
Forian Inc. (FORA) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.17 with +0.00% on the session and $67.8M in market capitalization; recent performance reads 1-month +0.00% and YTD +2.36%.
The latest financial table shown here is Q1 2026, with revenue of $6.9M, net income of $-3.4M, and EPS of $-0.11. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.8%.
The latest indexable market news headline is "VerticalScope Announces Strategic Investment in AltaML" from Business Wire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $4.50; recent insider activity includes McGrail Caroline Strickland filing D-Return. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.51
P/S
2.26
EV/EBITDA
-8.12
DCF Value
$-11.92
FCF Yield
2.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.8%
Operating Margin
-13.4%
Net Margin
-17.0%
ROE
-17.2%
ROA
-13.2%
ROIC
-14.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.9M | $-3.4M | $-0.11 |
| Q4 2025 | $8.0M | $-1.8M | $-0.06 |
| FY 2025 | $30.3M | $-2.9M | $-0.09 |
| Q3 2025 | $7.8M | $-151.2K | $-0.00 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$4.50
Target (Median)
$4.50
Target Range
$4.50 - $4.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
0.93
Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.